
What they do:
Decarbonizing the chemicals industry.
Quick facts:
HQ: Houston, TX, United States
This list has 15 startups and was last updated on Oct 15, 2026. 1 of them are hiring right now. Largest teams: Solugen, Ankr Health, and VenoStent. Latest round: FibroBiologics raised $1.2M (Oct 13, 2026).

What they do:
Decarbonizing the chemicals industry.
Quick facts:
HQ: Houston, TX, United States

What they do:
Absorbable wrap for blood vessels
Quick facts:
HQ: Houston, TX, United States
Funding:
$10M · Debt · May 2026

What they do:
Virtualizing brick-mortar infrastructures of clinics w/ generative AI
Quick facts:
HQ: Houston, TX, United States

What they do:
We built the world's first automated digital pathology lab.
Quick facts:
HQ: Houston, TX, United States

What they do:
AI enabling digital urine diagnostics in the home
Quick facts:
HQ: Houston, TX, United States

What they do:
The dynamic single-cell analysis company
Quick facts:
HQ: Houston, TX, United States

What they do:
Natural hydrogel to keep internal organs scar-free after surgery
Quick facts:
HQ: Houston, TX, United States

What they do:
Catheter-based solution to treat chronic heart failure.
Quick facts:
HQ: Houston, TX, United States
Quick facts:
HQ: Houston, TX, United States
Funding:
$22.5M · Equity · May 2026
Quick facts:
HQ: Houston, TX, United States
Funding:
$13.5M · Equity · Feb 2026
Quick facts:
HQ: Houston, TX, United States
Funding:
$4M · Equity · Jun 2026
Quick facts:
HQ: Houston, TX, United States
Funding:
$3.25M · Equity · Jun 2026
Quick facts:
HQ: Houston, TX, United States
Funding:
$1.2M · Equity + debt · Oct 2026

What they do:
Volumetric builds living multicellular tissues with a focus on the…
Quick facts:
HQ: Houston, TX, United States
What they do:
Advancing surgical precision through safe electrical stimulation.
Quick facts:
HQ: Houston, TX, United States
There are 15 startups on this list, last updated on Oct 15, 2026.
1 of them are hiring right now, including Ankr Health.
By team size: Solugen (200 employees), Ankr Health (30 employees), and VenoStent (17 employees).
Latest rounds: FibroBiologics — $1.2M Equity + debt (Oct 2026), Health for Everyone — $4M Equity (Jun 2026), and Goldenrod Therapeutics — $3.25M Equity (Jun 2026).